Financial & competing interests disclosure
RM Camire is supported by NIH grants P01 HL-74124 Project 2, R01 HL-88010 and research funding from Pfizer. The author also receives royalties from Pfizer for technology related to FXa. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.